DOUGLAS B GIVEN Insider Trading $ARWR ARROWHEAD PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOUGLAS B GIVEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOUGLAS B GIVEN. DOUGLAS B GIVEN is Director in AKSYS LTD ($AKSY) and Director in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR).
DOUGLAS B GIVEN in ARROWHEAD PHARMACEUTICALS, INC.
Trading Symbol: ARWRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOUGLAS B GIVEN: Director
Holdings: 114,868 shares
Current Value: $225,141
Latest Transaction: Jun 24 2021
$ARWR Market Capitalization: $149.83M
$ARWR Previous Close: $1.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DOUGLAS B GIVEN in ARROWHEAD PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 89.21 | 4,500 | 401,445 | 114,868 | 119.4 K to 114.9 K (-3.77 %) |
Feb 24 2021 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 88.73 | 1,125 | 99,821 | 13,875 | 15 K to 13.9 K (-7.50 %) |
Jan 19 2021 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 83.28 | 3,000 | 249,840 | 12,500 | 15.5 K to 12.5 K (-19.35 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 113,868 | 113.9 K to 113.9 K (-0.03 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 113,903 | 113.9 K to 113.9 K (-0.03 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 200 | 0 | 113,938 | 114.1 K to 113.9 K (-0.18 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 114,138 | 114.2 K to 114.1 K (-0.03 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 35 | 0 | 114,173 | 114.2 K to 114.2 K (-0.03 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 200 | 0 | 114,208 | 114.4 K to 114.2 K (-0.17 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 200 | 0 | 114,408 | 114.6 K to 114.4 K (-0.17 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 65 | 0 | 114,608 | 114.7 K to 114.6 K (-0.06 %) |
Dec 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 65 | 0 | 114,673 | 114.7 K to 114.7 K (-0.06 %) |
Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 79.59 | 500 | 39,795 | 15,000 | 15.5 K to 15 K (-3.23 %) |
Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 79.30 | 9,075 | 719,648 | 114,738 | 123.8 K to 114.7 K (-7.33 %) |
Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 15,500 | 0 | 15,500 | 0 to 15.5 K |
Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 15,500 | 0 | 15,500 | 0 to 15.5 K |
Dec 18 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 31,000 | 0 | 123,813 | 154.8 K to 123.8 K (-20.02 %) |
Apr 16 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 1,112 | 0 | 154,813 | 155.9 K to 154.8 K (-0.71 %) |
Apr 16 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 36.89 | 25,000 | 922,250 | 155,925 | 180.9 K to 155.9 K (-13.82 %) |
Apr 16 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 1,112 | 0 | 154,813 | 155.9 K to 154.8 K (-0.71 %) |
Apr 16 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 36.89 | 25,000 | 922,250 | 155,925 | 180.9 K to 155.9 K (-13.82 %) |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 4.75 | 7,000 | 33,250 | 0 | |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 2.62 | 10,000 | 26,200 | 7,000 | |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 2.19 | 18,000 | 39,420 | 17,000 | |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 5.19 | 30,000 | 155,700 | 35,000 | |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 19.25 | 65,000 | 1,251,250 | 175,130 | 240.1 K to 175.1 K (-27.07 %) |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 4.75 | 7,000 | 33,250 | 240,130 | 233.1 K to 240.1 K (+3.00 %) |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 2.62 | 10,000 | 26,200 | 233,130 | 223.1 K to 233.1 K (+4.48 %) |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 2.19 | 18,000 | 39,420 | 223,130 | 205.1 K to 223.1 K (+8.77 %) |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 5.19 | 30,000 | 155,700 | 205,130 | 175.1 K to 205.1 K (+17.13 %) |
Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 18.05 | 3,000 | 54,150 | 175,130 | 178.1 K to 175.1 K (-1.68 %) |
Jan 24 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 13.58 | 3,000 | 40,740 | 178,130 | 181.1 K to 178.1 K (-1.66 %) |
Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 36,000 | 0 | 181,130 | 145.1 K to 181.1 K (+24.81 %) |
Dec 28 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 12.00 | 3,000 | 36,000 | 145,130 | 148.1 K to 145.1 K (-2.03 %) |
Nov 26 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 12.74 | 3,000 | 38,220 | 148,130 | 151.1 K to 148.1 K (-1.99 %) |
Nov 26 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 12.74 | 3,000 | 38,220 | 148,130 | 151.1 K to 148.1 K (-1.99 %) |
Oct 23 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 3,870 | 0 | 151,130 | 155 K to 151.1 K (-2.50 %) |
Apr 25 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 6.63 | 25,000 | 165,750 | 155,000 | 180 K to 155 K (-13.89 %) |
Jan 03 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 30,000 | 0 | 180,000 | 150 K to 180 K (+20.00 %) |
Jan 04 2017 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 80,000 | 0 | 150,000 | 70 K to 150 K (+114.29 %) |
Oct 18 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 6.72 | 12,000 | 80,640 | 70,000 | 82 K to 70 K (-14.63 %) |
Oct 18 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Gift | G | 0.00 | 8,000 | 0 | 82,000 | 90 K to 82 K (-8.89 %) |
Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 35,000 | 0 | 90,000 | 55 K to 90 K (+63.64 %) |
Mar 06 2015 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 35,000 | 0 | 55,000 | 20 K to 55 K (+175.00 %) |
Page: 1